Read the Research

Handfuls of hair in the shower drain, on the pillow, in the hairbrush: for a large proportion of new mothers, this becomes a daily reality somewhere around t...

Finasteride and dutasteride are both 5-alpha reductase inhibitors used to treat androgenetic alopecia, and they are frequently discussed as interchangeable o...

Dutasteride is a more complete 5-alpha reductase inhibitor than finasteride, and the interest in a topical version follows the same logic that drove topical ...

Finasteride at 1mg oral is one of the most effective interventions available for androgenetic alopecia, with decades of randomised trial data supporting its ...

Minoxidil is the most widely used topical treatment for hair loss in the world. It has been studied in randomised controlled trials for over four decades, it...

Hair loss that develops without obvious patterning or a clear genetic history tends to prompt questions about nutrition. The instinct is reasonable: hair fol...

Androgenetic alopecia is the most prevalent form of hair loss in adults. It affects an estimated 50% of men by the age of 50 and a significant proportion of ...

The Wnt/beta-catenin pathway appears repeatedly in any serious reading around hair follicle biology and hair loss. It comes up in discussions of follicle dev...

Hair loss research has long focused on two principal targets: the androgen pathway (addressed by finasteride and dutasteride) and vascular and anagen-prolong...

People using minoxidil as the backbone of a hair loss protocol often want to add further topical actives. 2-Deoxy-D-Ribose is among the more commonly asked-a...